The defective myocardial performance responsible for the syndrome of congestive heart failure has been considered for many years to involve a biochemical abnormality. However, identification of this abnormality remains to be achieved. Muscle cell function is basically a process by which chemical energy is transformed into the mechanical work of myofibrillar shortening and force development. The presence of a biochemical abnormality in the failing cardiac muscle must therefore be sought either in the mechanism of energy production or in the mechanism of energy utilization by the contractile system. The present report is a study of energy production in the failing human heart. Considerable evidence has accumulated to indicate that myocardial extraction of oxygen and of oxidizable substrates is not diminished in patients with congestive heart failure (1-3). These studies have not, however, provided evidence that the final supply of chemical energy to the contractile apparatus is normal. ATP, the immediate source of chemical energy utilized by muscle (4), is formed within the mitochondrion during the oxidation of substrates by the process of oxidative phosphorylation. The completeness with which the process of phosphorylation is coupled to that of oxidation determines whether or not the energy liberated in the oxidation of substrates becomes available for useful mechanical work by the contractile apparatus. A number of toxic agents have been shown to be capable of uncoupling electron transport and phosphorylation, both in vitro (5)
and in vivo (6, 7) , and one clinical syndrome, characterized by nonthyroid hypermetabolism and resulting from uncoupling of these two processes, has been identified by Luft and associates (8) .
Mitochondrial function in the failing heart has previously been studied only in experimental animals, where the findings have been conflicting. Oxidative phosphorylation and the content of high energy phosphate compounds have been reported to be normal in some of these studies (9) (10) (11) (12) , whereas in others defective energy production has been observed (13) (14) (15) (16) (17) . Thus, it seemed evident that this problem, in the clinical syndrome of congestive heart failure, could be solved definitively only by studying mitochondrial function and morphology and the content of high energy phosphate compounds in human myocardial tissue. Accordingly, the present study was carried out with myocardial tissue removed at the time of cardiac operations from 25 patients with congestive heart failure. Mitochondria isolated from these tissues were shown to possess a high degree of structural and functional integrity, and the myocardial content of high energy phosphate compounds was not found to be reduced. We concluded, therefore, that there is no evidence for a biochemical abnormality of energy production in the failing human heart.
Methods
This type of investigation on viable human cardiac tissue is now possible because of the development and application of effective surgical methods for prosthetic replacement of cardiac valves. Papillary muscles were removed from 14 patients with heart failure; in 13 patients, muscles were obtained from the left ventricle at the time of removal of diseased mitral valves, and in one patient muscles were obtained from the right ventricle during excision of the tricuspid valve. In all patients rheumatic heart disease was responsible for the valvular deformity, and all were on maintenance digoxin. The patients, seven men and seven women, were 21 to 57 years of age. The major hemodynamic abnormality in ten patients was mitral regurgitation; in one patient, mitral stenosis; in one patient, tricuspid regurgitation; and in two patients, combined aortic and mitral disease, necessitating replacement of both the aortic and mitral valves. Hemodynamic evaluation by right and left heart catheterization was carried out in all 14 patients who comprised this study. To represent nonfailing hearts, mitochondria also were prepared from right ventricular outflow tract muscle removed from two male patients with tetralogy of Fallot during correction of this congenital defect.
The general methods utilized in this clinic for mitral valve replacement have been previously described in detail (18) . The preoperative medications were pentobarbital, atropine, and meperidine. Anesthesia was induced with thiopental and maintained with halothane in a concentration of 0.5 to 1.0%. The mitral valve was exposed during total cardiopulmonary bypass, and after the valve leaflets had been detached from the anulus, the papillary muscles were divided from the ventricular wall at their origins and the valve and muscles removed en bloc. (20) . Mitochondria also were prepared from adult (700 to 900 g) guinea pigs; left ventricles were pooled from two to three animals and treated in the same manner as the human tissues, except that incubation with Nagarse enzyme was for 10 minutes.
Studies of mitochondrial function were done immediately.
Oxidative phosphorylation was studied by techniques similar to those described previously (21 Tissues for examination with the electron microscope were removed during cardiac operations in four patients with failure (AYF., C.J., V.M., and M.P.) and in three patients with atrial and ventricular septal defects and no history of failure. Specimens were immediately stretched and mounted on hard rubber at a minimal tension and fixed in osmium tetraoxide buffered to pH 7.4 with phosphate (27) . The specimens were dehydrated in alcohol, embedded in Epon, sectioned, and examined in an RCA (model EMU-3G) electron microscope.
Results
Hemodynamic data. The 22 patients from whom either papillary muscles were removed for 2 McDonald Equipment Co., Cleveland, Ohio. 3 Sigma Chemical Co., St. Louis, Mo. mitochondrial studies or biopsies were taken for determination of high energy phosphate compounds, and whose hemodynamic status is presented in Table I , all had symptoms of markedly reduced cardiac reserve and were in functional classes III or IV. Atrial fibrillation was present in 14. The cardiac index was 2.4 L per minute per M2, the lower limit of normal, or less in all but three patients, and in ten patients it was markedly reduced to below 2.0 L per minute per M2. Severe pulmonary hypertension, indicated by a pulmonary arterial systolic pressure greater than 50 mm Hg, was present in 12 of the patients, and the mean left atrial pressure exceeded 12 mm Hg in all but two of the 17 patients in whom this measurement was made. The left ventricular enddiastolic pressure was 12 mm Hg or greater in 13 patients. One patient (C.J.) was too ill to be studied immediately before operation, and the data reported are those obtained at catheterization 2 years earlier. The mitral valve alone was replaced in 12, both the mitral and aortic in three, the aortic valve alone in six, and the tricuspid alone in one. The two patients with tetralogy of Fallot had pronounced right ventricular hypertension but no evidence of heart failure.
Mitochondrial function. The manometric studies conducted with mitochondria derived from the 11 patients with rheumatic heart disease demonstrated a normal capacity for oxidative phosphorylation (Table II) . The yield of mitochondria averaged 9 (Table II) . The data are similar except that the oxidative rates were somewhat less with the preparations from the experimental animal. The rate of oxidation with succinate was less than with pyruvate-malate, and respiratory control with succinate was absent when measured manometrically in both the guinea pig and human mitochondria.
Polarographic measurement of oxidative phosphorylation in mitochondrial preparations obtained from three patients (L.S., R.F., and P.R.) also revealed that coupling between electron transport and phosphorylation was preserved in the iso- with a-ketoglutarate. Respiratory control ratios averaged 5.6 (4.4 to 7.0) with pyruvate-malate, 3.9 (3.8 to 3.9) with succinate, and 5.6 (4.9 to 6.3) with a-ketoglutarate. In these incubations (less than 5 minutes) significant respiratory control could be demonstrated with succinate as the substrate, whereas it was not.present in the longer manometric incubations. In each study, uncoupling by 2,4-dinitrophenol released respiratory control (Figures 1 and 2) , and maximal rates of oxidation, comparable to those obtained with ADP, were achieved.
ATPase activity was determined in mitochondria isolated from the muscles of eight patients with rheumatic heart disease and from one patient with tetralogy of Fallot (Table III) . The endogenous activity averaged 0.22 umole of phosphate liberated per mg of mitochondrial protein per 10 minutes. This activity increased to 0.59 in the presence of magnesium ion. A pronounced increase in activity was observed in the presence of 2,4-dinitrophenol. This augmented activity was completely inhibited in the presence of oligomycin. Since oligomycin is a specific inhibitor of mitochondrial ATPase activated by 2,4-dinitrophenol (28), this response is evidence that the enzyme activity that has been determined is truly of mitochondrial origin and not due to contamination by Table I ). Mitochondria in the same range of size as those in A are present. The cristae filling the organelle appear to be comparable to those seen in mitochondria of the nonfailing heart. Myofibrils are shown in longitudinal section, and the typical sarcomere pattern (29) is present without visable derangement. C) and D) Mitochondria in left ventricular tissue removed from a patient with severe heart failure (M.P., Table I ). The mitochondria are shown in situ, C, and in vitro after isolation, D. Some swelling of the organelle has occurred as a result of the isolation, but this swelling is minimal. No structures of nonmitochondrial origin are visible.
other cellular constituents. In a single experi-tients with tetralogy of Fallot (J.B.), comparable ment using mitochondria prepared from the right values were obtained. ventricular tissue removed from one of the paMitochondrial morphology. Examination of the fine structure of mitochondria in tissues removed from patients with heart failure did not disclose any structural alterations when compared to mitochondria in tissues obtained from patients without heart failure ( Figure 3) . The over-all size of the organelle in situ was not increased in the failing heart, and the structure of the cristae as well as that of the matrix did not exhibit any apparent abnormality. Furthermore, examination of these mitochondria even after isolation revealed no aberrations in the mitochondrial profiles, although there was some swelling that is commonly seen in all isolated preparations. No attempt was made to quantify with precision the mitochondrial concentration in the sarcoplasm, but no gross increase in the number of mitochondria was apparent when the morphology of the failing myocardium was compared to that of the nonfailing tissue. Myocardial high energy phosphate. By the biopsy method for determination of high energy phosphate compounds in the canine myocardium, the concentration of creatine phosphate averaged of both compounds were lower than in the dogs. The concentrations of creatine phosphate were essentially the same in myocardial biopsies taken from eight patients without cardiac decompensation and 14 patients with congestive failure, averaging 3.9 + 0.5 and 4.0 ± 0.9 umoles per g, respectively (Figure 4) . The inorganic phosphate concentrations, which are not presented in the Figure, 
Discussion
Previous studies of energy production in clinical heart failure have been limited to an evaluation of the myocardial utilization of substrates and oxygen, based on measurements of arteriovenous differences and coronary blood flow (1) (2) (3) . Although this approach demonstrated that substrate and oxygen utilization per 100 g of myocardium was normal at rest in patients with congestive heart failure, and increased appropriately during exercise, there are certain definite limitations of these methods that must be emphasized. First, the exchange of substrate and oxygen at the level of the vascular bed does not necessarily indicate the extent to which this potential chemical energy becomes available for useful cellular work, and this can be answered only by demonstrating that the conversion of substrate energy to high energy phosphate compounds within the cell is normal. Any such defect in oxidative phosphorylation would result in subnormal energy production even in the presence of normal or increased oxygen and substrate utilization. Furthermore, the use of the inert gas method to measure total coronary blood flow may not be entirely valid, particularly when nonhomogeneous perfusion and nonsteady states pertain (30, 31). Thus, it is possible that abnormalities of energy metabolism might exist in the failing heart and remain undetected by studies of coronary sinus catheterization (32) .
The mitochondrion is the intracellular structure in which the chemical energy contained within substrates is converted into a form available for cellular utilization. By means of oxidative phosphorylation, a part of the free energy released during the transport of electrons from substrate to oxygen is retained in high energy intermediates that ultimately result in the formation of ATP (33) . Studies have been carried out with mitochondria isolated from the ventricles of experimental animals in heart failure to determine whether there was an abnormality of oxidative phosphorylation, and conflicting results have been obtained. In acutely failing ventricles, oxidative phosphorylation was found to be normal in some studies (10) and depressed in others (34) . Similarly, no agreement has been reached regarding oxidative phosphorylation in chronically failing experimental preparations. There have been reports that right heart failure in the dog, produced by tricuspid insufficiency and pulmonary stenosis, does not interfere with mitochondrial function (17) . However, a detailed investigation in the guinea pig has shown that chronic left ventricular failure is accompanied by an alteration of oxidative phosphorylation manifested by a reduction of P/O and of respiratory control ratios (11) . Also, studies of mitochondria isolated from the hypertrophied but nonfailing canine left ventricle have demonstrated abnormal oxidative phosphorylation (35) . Diminished myocardial concentrations of the mitochondrial enzyme, malic dehydrogenase, also have been found in the hypertrophied canine ventricle (35) . Similar reductions of this and other mitochondrial enzymes were reported in postmortem specimens obtained from patients with heart failure (32).
We have attempted to evaluate mitochondrial function in the human heart using tissue obtained from left ventricular papillary muscles removed at the time of mitral valve replacement (18) . This tissue has provided the only opportunity to measure in vitro the functional capacity of mitochondria from the viable human heart, as opposed to study of postmortem tissue where variable degrees of autolysis may be present. The results indicate that, in vitro, electron transport is tightly coupled to phosphorylation in the mitochondria prepared from ventricular tissue removed from patients who clearly exhibited hemodynamic evidence of heart failure (Table I) . Thus, P/O ratios closely approximated the expected normal values with pyruvate-malate or succinate as substrate. The more sensitive index of coupled phosphorylation, the respiratory control ratio (24) , has also confirmed the functional integrity of these organelles (Figures 1 and 2) . Furthermore, these findings have been supported by measurements of mitochondrial ATPase activities, which have indicated that the endogenous enzyme activity of the mitochondria can be augmented greatly by 2,4-dinitrophenol, a reagent that uncouples oxidative phosphorylation. The 15-fold increase in ATPase with 2,4-dinitrophenol demonstrates that, even after isolation of the mitochondria, only minimal functional derangement could be present, since no such augmentation would occur in damaged mitochondria (33) . The measurements of oxidative phosphorylation in two patients with tetralogy of Fallot, and of ATPase activity in one of these, provide further control observations of mitochondria from nonfailing hearts for comparison with the studies carried out with mitochondria from failing hearts. The results of these measurements were similar in both groups of patients: However, it should be recognized that these mitochondria were assayed in a fortified medium in which optimal concentrations of substrates, cofactors, and oxygen were present. It is still possible that in situ the cardiac mitochondria are not so richly endowed.
Since morphologic changes of the mitochondria also have been described in the hypertrophied but nonfailing canine ventricle (36) and in the failing rabbit ventricle after aortic constriction (15) , attention also was directed to the structural characteristics of mitochondria examined in biopsies of these failing human hearts (Figure 3 ). When these mitochondria were compared with mitochondria examined in nonfailing hearts, no gross abnormality of their structure or number was noted. Biopsies from only four patients with heart failure were studied, and it may be questioned whether these observations are representative of the most advanced ventricular failure. However, the hemodynamic data in three of these patients indicated marked left ventricular failure with cardiac indexes 1.8 per L minute per m2 or below, pulmonary arterial systolic pressure of 65 mm Hg or more, and elevated left ventricular end diastolic pressure in two of three patients. The fourth patient (C.J.) was too ill to be studied before operation and required replacement of both the aortic and mitral valves. A specific effort was not directed toward an evaluation of sarcomere structure, but no gross derangement of this basic contractile unit (29) was noted in the sections of failing myocardium that were examined ( Figure  3) . Specifically, there was no increase of the central H-zone as described in acutely dilated canine hearts (37) . It must be emphasized in this regard, however, that it was not possible to fix the tissues at either tensions or muscle lengths necessarily corresponding to those present in vivo, and such a method of fixation would be required to evaluate this point critically.
The amount of energy available to the contractile apparatus also has been studied in heart failure in the experimental animal. Again, the results have been conflicting, with some reports indicating depressed concentrations of creatine phosphate and ATP (12, 13, 38, 39) and others no change (9, 17) . The determination of creatine phosphate is difficult because of its extreme lability in tissue biopsies (25) . Thus, many studies in which this phosphate compound has been measured were complicated by substantial hydrolysis of the material before the specimen was frozen. The method employed in the present study for determination of creatine phosphate in the human heart was first used in the dog. With this method values were obtained that were comparable to the highest reported myocardial creatine phosphate concentrations (25) ; no consistent difference was encountered in the concentrations determined in the right and left ventricles. Therefore, we believe that the creatine phosphate and ATP concentrations reported in these studies of the human heart are based on valid methods and that the comparison between the biopsies of the right ventricle in the patients without heart failure and those of the left ventricle in the patients with failure are justified.
A wide range of values, which may be the result of the variability of local myocardial perfusion in the biopsied tissue, was encountered in both groups of patients. Although no reduction of the content of high energy phosphate compounds was detected in these patients, it must be emphasized that a small but functionally important reduction in either creatine phosphate or ATP might have been present but not observed because of the range of variation encountered in these observations. The low level of creatine phosphate observed in both groups of patients, especially when compared to the ATP concentration, is notable. Although equal amounts of creatine phosphate and ATP were found in these human biopsies, in the dog the concentration of creatine phosphate is approximately three times that of ATP.
Thus, oxidative phosphorylation, when studied under optimal in vitro conditions, was normal in mitochondria obtained from the failing human heart, and a significant reduction in the myocardial content of high energy phosphate compounds was not detected by methods employed in this study. Although there are certain limitations to the interpretation of these findings, which have been previously emphasized, it seems unlikely that an abnormality of energy production can be responsible for the defective myocardial performance in heart failure. Some consideration must be given to the differences in observations made in the present study and in previous studies in the experimental animal. It is possible that the severity of heart failure was greater in the experimental preparations and that, if mitochondria from patients with more advanced heart failure had been studied, an abnormality might have been detected. The hemodynamic burden of mitral regurgitation that was present in many of these patients may not be so stressful as the experimental lesions imposing outflow obstructions. Several patients with aortic stenosis were also studied, however, and an impairment of energy production was not detected by the methods used in this study. It may be questioned whether tissue from papillary muscles is representative of the mural ventricular contractile mass. Recently, a depression of the lengthtension relationship has been demonstrated in such muscles obtained from failing human hearts (40) , and, therefore, it seems justifiable to consider these papillary tissues as representative of the failing heart. Also, digitalis therapy, which was present in all of these patients, may have had some influence on these measurements, although its acute administration -was without effect on the abnormality of energy production in experimental failure (11) . Finally, it is possible that the differences that have been encountered are due to the rate of development of ventricular failure. In the clinical setting, cardiac failure has a relatively slow onset, whereas, even in the chronic failure preparations in experimental animals, outflow obstruction is produced acutely. An 4 .0 umoles per g compared to 3.9 umoles per g in biopsies from patients without heart failure. Similarly, no significant reduction of ATP was found in the failing heart. These observations have indicated that electron transport and coupled phosphorylation were normal in mitochondria isolated from failing human hearts when functional studies were carried out under optimal in sitro conditions, and that there was no detectable reduction of the content of high energy phosphate compounds in these hearts. Although there are certain limitations to the interpretation of these findings, it seems unlikely that energy production in the myocardium is necessarily impaired in patients with pronounced congestive heart failure. If a biochemical abnormality is responsible for the defective ventricular function in such patients, it would appear to involve the utilization of energy in the contractile process.
